On November 19, Peter Schmidtke, Product Owner, will participate in CCG’s workshops to present the science and technology behind Discngine’s newest product, 3dpredict/Ab, a cloud-based SaaS platform for ensemble-based antibody structure prediction and liability property calculations.
Discngine at CCG’s Drug Design Workshops in Cambridge, UK
Previous
Previous
3dpredict/Ab release 2025.12
Next
Next